Vir Biotechnology’s (VIR) “Buy” Rating Reiterated at Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of Vir Biotechnology (NASDAQ:VIR – Free Report) in a research report released on Thursday morning,Benzinga reports. Needham & Company LLC currently has a $14.00 price objective on the stock. Several other research firms also recently weighed in on VIR. HC Wainwright reissued a “buy” rating […]
Needham & Company LLC reissued their buy rating on shares of Vir Biotechnology (NASDAQ:VIR – Free Report) in a research report released on Thursday morning,Benzinga reports. Needham & Company LLC currently has a $14.00 price objective on the stock. Several other research firms also recently weighed in on VIR. HC Wainwright reissued a “buy” rating […]
